AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2018
May 8, 2018
284_dirs_2018-05-08_516a746f-389e-4130-b3a5-b59e55780e3c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2018-05-04
Reporting Person: FRAZIER KENNETH C (Director, Chairman, President & CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-05-04 | Stock Option (right to buy) | $57.7500 | A | 475743.0000 | Acquired | 2028-05-03 | Common Stock (475743.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 710697.0630 | Direct |
| Common Stock - 401(k) Plan | 3937.2884 | Indirect |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: Includes shares acquired and dividends earned through April 6, 2018, in the Merck U.S. Savings Plan, a 401(k) plan.
F3: The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8